3.50
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.14%
113.04
|
106.51 | 47.71 | 122.06 | 85.24 |
|
|
5.98%
11.31
|
12.03 | - | - | - |
| Costs And Expenses |
0.59%
33.73
|
33.93 | 40.90 | 46.58 | 39.92 |
| Operating Income/Loss |
9.28%
79.31
|
72.57 | 6.805 | 75.48 | 45.32 |
| Nonoperating Income/Loss |
24.66%
-5.576
|
-7.401 | -6.35 | -7.464 | -7.499 |
| Income/Loss From Continuing Operations Before Tax |
13.13%
73.73
|
65.17 | 6.805 | 68.02 | 37.82 |
| Income Tax Expense/Benefit |
8.03%
22.44
|
24.40 | 2.731 | 27.94 | 14.22 |
|
|
25.80%
51.29
|
40.77 | -2.276 | 40.08 | 23.60 |
| Basic Average Shares |
0.58%
164.41
|
163.45 | 0.20 | 162.22 | 161.72 |
| Diluted Average Shares |
0.29%
167.18
|
166.69 | -14.07 | 177.76 | 176.84 |
| Basic Earnings Per Share |
24.00%
0.31
|
0.25 | -0.01 | 0.25 | 0.15 |
| Diluted Earnings Per Share |
29.17%
0.31
|
0.24 | -0.01 | 0.23 | 0.14 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):